Sinaptica Therapeutics
Sinaptica Therapeutics™
Cambridge, United States · $21.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Website
- sinapticatx.com
- Total Funding
- $21.0M
- Last Round
- $21.0M Series ANov 2023
- Rounds
- 2
About
Clinical-stage company developing personalized closed-loop neuromodulation therapy for Alzheimer's Disease.
Summary
Sinaptica Therapeutics is a Biotech company based in Cambridge, United States. It has raised $21.0M in total across 2 rounds, most recently a $21.0M Series A round in Nov 2023. Investors include Asymmetry Ventures and Sony.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company